Course of weight gain and metabolic abnormalities in first treated episode of psychosis: the first year is a critical period for development of cardiovascular risk factors

Is the Prevalence of Metabolic Syndrome and Metabolic Abnormalities Increased in Early Schizophrenia? A Comparative Meta-Analysis of First Episode, Untreated and Treated Patients

(2012) A. J. Mitchell et al.   SCHIZOPHRENIA BULLETIN

Systematic Review of Early Cardiometabolic Outcomes of the First Treated Episode of Psychosis

(2011) Debra L. Foley et al.   ARCHIVES OF GENERAL PSYCHIATRY

Metabolic and cardiovascular adverse effects associated with antipsychotic drugs

(2011) Marc De Hert et al.   Nature Reviews Endocrinology

Treatment with antipsychotics and the risk of diabetes in clinical practice

(2010) Lars Vedel Kessing et al.   BRITISH JOURNAL OF PSYCHIATRY

Incidence of type 2 diabetes in southern Spain (Pizarra Study)

(2010) F. Soriguer et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Antipsychotics Associated with the Development of Type 2 Diabetes in Antipsychotic-Naïve Schizophrenia Patients

(2010) Jimmi Nielsen et al.   NEUROPSYCHOPHARMACOLOGY

Tolerability of outpatient antipsychotic treatment: 36-month results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study

(2009) Diego Novick et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Predictors of Antipsychotic-Induced Weight Gain in First-Episode Psychosis

(2009) Sahoo Saddichha et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Contributing factors to weight gain during long-term treatment with second-generation antipsychotics. A systematic appraisal and clinical implications

(2009) S. Gentile   Obesity Reviews

Weight gain in antipsychotic-naive patients: a review and meta-analysis

(2009) I. Tarricone et al.   PSYCHOLOGICAL MEDICINE

Epidemiological factors associated with treated incidence of first-episode non-affective psychosis in Cantabria: insights from the Clinical Programme on Early Phases of Psychosis

(2008) José M. Pelayo-Terán et al.   Early Intervention in Psychiatry

Prevalence and associations of the metabolic syndrome among patients prescribed clozapine

(2008) M. Ahmed et al.   IRISH JOURNAL OF MEDICAL SCIENCE

Typical and atypical antipsychotics differentially affect long-term incidence rates of the metabolic syndrome in first-episode patients with schizophrenia: A retrospective chart review

(2008) Marc De Hert et al.   SCHIZOPHRENIA RESEARCH

Glucose and lipid disturbances after 1 year of antipsychotic treatment in a drug-naïve population

(2008) Rocio Perez-Iglesias et al.   SCHIZOPHRENIA RESEARCH

Weight gain induced by haloperidol, risperidone and olanzapine after 1 year: Findings of a randomized clinical trial in a drug-naïve population

(2007) Rocio Perez-Iglesias et al.   SCHIZOPHRENIA RESEARCH